AIIRA VA Recommendations for Use

A VA Cooperative Study, Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D), was terminated early based on a greater number of observed acute kidney injury events (HR 1.7 95% CI 1.3 to 2.2; P ................
................